78 related articles for article (PubMed ID: 16157221)
41. Proteomic profiling of canine fibrosarcoma and adjacent peritumoral tissue.
Beebe E; Pöschel A; Kunz L; Wolski W; Motamed Z; Meier D; Guscetti F; Nolff MC; Markkanen E
Neoplasia; 2023 Jan; 35():100858. PubMed ID: 36508875
[TBL] [Abstract][Full Text] [Related]
42. MicroRNA‑218 inhibits the malignant phenotypes of glioma by modulating the TNC/AKT/AP‑1/TGFβ1 feedback signaling loop.
Dang S; Zhang R; Tian S; Hou P; Li G; Ji M
Int J Mol Med; 2021 Nov; 48(5):. PubMed ID: 34558654
[TBL] [Abstract][Full Text] [Related]
43. Biological Heterogeneity of Chondrosarcoma: From (Epi) Genetics through Stemness and Deregulated Signaling to Immunophenotype.
Zając A; Król SK; Rutkowski P; Czarnecka AM
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33804155
[TBL] [Abstract][Full Text] [Related]
44. Expression Changes and Impact of the Extracellular Matrix on Etoposide Resistant Human Retinoblastoma Cell Lines.
Reinhard J; Wagner N; Krämer MM; Jarocki M; Joachim SC; Dick HB; Faissner A; Kakkassery V
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560557
[TBL] [Abstract][Full Text] [Related]
45. Tenascin-C Modulates Cell Cycle Progression to Enhance Tumour Cell Proliferation through AKT/FOXO1 Signalling in Pancreatic Cancer.
Cai J; Lu W; Du S; Guo Z; Wang H; Wei W; Shen X
J Cancer; 2018; 9(23):4449-4462. PubMed ID: 30519351
[TBL] [Abstract][Full Text] [Related]
46. Chondrosarcoma: A Rare Misfortune in Aging Human Cartilage? The Role of Stem and Progenitor Cells in Proliferation, Malignant Degeneration and Therapeutic Resistance.
Boehme KA; Schleicher SB; Traub F; Rolauffs B
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29361725
[TBL] [Abstract][Full Text] [Related]
47. No preclinical rationale for IGF1R directed therapy in chondrosarcoma of bone.
Peterse EF; Cleven AH; De Jong Y; Briaire-de Bruijn I; Fletcher JA; Danen EH; Cleton-Jansen AM; Bovée JV
BMC Cancer; 2016 Jul; 16():475. PubMed ID: 27418340
[TBL] [Abstract][Full Text] [Related]
48. The matrikine tenascin-C protects multipotential stromal cells/mesenchymal stem cells from death cytokines such as FasL.
Rodrigues M; Yates CC; Nuschke A; Griffith L; Wells A
Tissue Eng Part A; 2013 Sep; 19(17-18):1972-83. PubMed ID: 23541003
[TBL] [Abstract][Full Text] [Related]
49. The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma.
Sirica AE
Nat Rev Gastroenterol Hepatol; 2011 Nov; 9(1):44-54. PubMed ID: 22143274
[TBL] [Abstract][Full Text] [Related]
50. Tenascin-C enhances pancreatic cancer cell growth and motility and affects cell adhesion through activation of the integrin pathway.
Paron I; Berchtold S; Vörös J; Shamarla M; Erkan M; Höfler H; Esposito I
PLoS One; 2011; 6(6):e21684. PubMed ID: 21747918
[TBL] [Abstract][Full Text] [Related]
51. The functional role of reactive stroma in benign prostatic hyperplasia.
Schauer IG; Rowley DR
Differentiation; 2011; 82(4-5):200-10. PubMed ID: 21664759
[TBL] [Abstract][Full Text] [Related]
52. Tenascin-C promotes melanoma progression by maintaining the ABCB5-positive side population.
Fukunaga-Kalabis M; Martinez G; Nguyen TK; Kim D; Santiago-Walker A; Roesch A; Herlyn M
Oncogene; 2010 Nov; 29(46):6115-24. PubMed ID: 20729912
[TBL] [Abstract][Full Text] [Related]
53. Cartilage tumours and bone development: molecular pathology and possible therapeutic targets.
Bovée JV; Hogendoorn PC; Wunder JS; Alman BA
Nat Rev Cancer; 2010 Jul; 10(7):481-8. PubMed ID: 20535132
[TBL] [Abstract][Full Text] [Related]
54. Thrombospondin 1 binding to calreticulin-LRP1 signals resistance to anoikis.
Pallero MA; Elzie CA; Chen J; Mosher DF; Murphy-Ullrich JE
FASEB J; 2008 Nov; 22(11):3968-79. PubMed ID: 18653767
[TBL] [Abstract][Full Text] [Related]
55. Tenascin-C promotes cell survival by activation of Akt in human chondrosarcoma cell.
Jang JH; Chung CP
Cancer Lett; 2005 Nov; 229(1):101-5. PubMed ID: 16157221
[TBL] [Abstract][Full Text] [Related]
56. Bone morphogenetic protein-2 enhances the motility of chondrosarcoma cells via activation of matrix metalloproteinase-13.
Hou CH; Hsiao YC; Fong YC; Tang CH
Bone; 2009 Feb; 44(2):233-42. PubMed ID: 19038372
[TBL] [Abstract][Full Text] [Related]
57. TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathways.
Secchiero P; Gonelli A; Carnevale E; Milani D; Pandolfi A; Zella D; Zauli G
Circulation; 2003 May; 107(17):2250-6. PubMed ID: 12668516
[TBL] [Abstract][Full Text] [Related]
58. Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors.
Sinha D; Wang Z; Ruchalski KL; Levine JS; Krishnan S; Lieberthal W; Schwartz JH; Borkan SC
Am J Physiol Renal Physiol; 2005 Apr; 288(4):F703-13. PubMed ID: 15572521
[TBL] [Abstract][Full Text] [Related]
59. Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression.
Das R; Philip S; Mahabeleshwar GH; Bulbule A; Kundu GC
IUBMB Life; 2005 Jun; 57(6):441-7. PubMed ID: 16012053
[TBL] [Abstract][Full Text] [Related]
60. Tenascin-C Signaling in melanoma.
Shao H; Kirkwood JM; Wells A
Cell Adh Migr; 2015; 9(1-2):125-30. PubMed ID: 25482624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
